Emergent Biosolutions Enhances Executive Retention Bonuses
TipRanksApr 26 16:44 ET
Amneal Pharmaceuticals Cleared by FDA to Sell Generic Version of Nasal Spray to Treat Opioid Overdose -- Shares Rise
Amneal Pharmaceuticals (AMRX) rallied Wednesday after the US Food and Drug Administration approved its generic version of the nasal spray used to treat opioid overdose. Amneal's Naloxone HCI nasal spr
MT NewswiresApr 24 15:25 ET
FDA Approves Amneal's Generic Version of OTC Narcan
Seeking AlphaApr 24 11:01 ET
Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024
GAITHERSBURG, Md., April 22, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Wednesday, May 1, 2024, at 5:00 pm eastern time to discuss the financial results for the first
GlobeNewswireApr 22 08:05 ET
Express News | NYSE Order Imbalance 76629.0 Shares on Buy Side 76629.0 Shares on Buy Side
Moomoo 24/7Apr 19 15:50 ET
Institutional Owners May Take Dramatic Actions as Emergent BioSolutions Inc.'s (NYSE:EBS) Recent 16% Drop Adds to One-year Losses
Yahoo FinanceApr 17 10:44 ET
Express News | Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $5 Price Target
Moomoo 24/7Apr 11 09:05 ET
Analysts' Top Healthcare Picks: Emergent Biosolutions (EBS), Vera Therapeutics (VERA)
TipRanksApr 11 07:20 ET
Express News | Emergent BioSolutions Receives NAI Status For Baltimore Bayview Manufacturing Facility
Moomoo 24/7Mar 25 08:10 ET
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility
GAITHERSBURG, Md., March 25, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced that the U.S. Food and Drug Administration (FDA) has listed "No Action Indicated" or NAI status classification for
GlobeNewswireMar 25 08:05 ET
Sector Update: Health Care Stocks Higher in Afternoon Trading
Health care stocks rose Tuesday afternoon with the NYSE Health Care Index increasing 0.6% and the Health Care Select Sector SPDR Fund (XLV) gaining 0.5%.
MT NewswiresMar 12 14:02 ET
Emergent BioSolutions Tumbles After S&P Global Credit Downgrade
Emergent BioSolutions (EBS) shares slumped Tuesday after S&P Global Ratings cut its credit rating for the vaccine manufacturer deeper below investment grade, saying the company may not be able to refi
MT NewswiresMar 12 13:41 ET
Emergent BioSolutions Inc (EBS) Reports Mixed Fourth Quarter and Full Year 2023 Financial Results
Yahoo FinanceMar 7 13:58 ET
Express News | Emergent Biosolutions Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Financial Results and Issued FY24 Revenue Guidance Below Estimates
Moomoo 24/7Mar 7 12:52 ET
Viking Therapeutics, Creative Medical Technology, Aptorum Group Among Healthcare Movers
Seeking AlphaMar 7 11:37 ET
Emergent Biosolutions Raised to Buy From Hold by Benchmark
Emergent Biosolutions Raised to Buy From Hold by Benchmark
Dow JonesMar 7 10:48 ET
Express News | Benchmark Upgrades Emergent BioSolutions to Buy, Announces $5 Price Target
Moomoo 24/7Mar 7 10:39 ET
Emergent BioSolutions Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/07/2024 94.55% Benchmark → $5 Upgrades Hold → Buy 11/20/2023 — JP Morgan Reinstates → Underweight 08/2
BenzingaMar 7 10:37 ET
PWM, RVSN and AISP Among Pre-market Losers
Seeking AlphaMar 7 08:35 ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersNKGen Biotech (NASDAQ:NKGN) stock rose 18.0% to $2.16 during Thursday's pre-market session. The company's market cap stands at $47.2 million. Nutex Health (NASDAQ:NUTX) stock increased by 15.32
BenzingaMar 7 08:06 ET
No Data
No Data